Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).

Saved in:
Bibliographic Details
Title: Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
Authors: Fiskus W; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Boettcher S; University of Zurich and University Hospital Zurich, CH-8091, Zurich, Switzerland., Daver N; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Mill CP; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Sasaki K; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Birdwell CE; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Davis JA; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Takahashi K; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Kadia TM; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., DiNardo CD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Jin Q; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Qi Y; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Su X; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., McGeehan GM; Syndax Pharmaceuticals, Inc., Waltham, MA, 02451, USA., Khoury JD; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA., Ebert BL; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Bhalla KN; The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA. kbhalla@mdanderson.org.
Source: Blood cancer journal [Blood Cancer J] 2022 Jan 11; Vol. 12 (1), pp. 5. Date of Electronic Publication: 2022 Jan 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2044-5385
DOI:10.1038/s41408-021-00603-3